YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk pens acquisition

Posted online

Novo Nordisk announced plans for a new acquisition.

The Danish pharmaceutical company agreed to buy Germany-based Cardior Pharmaceuticals for $1.1 billion.

Cardior makes therapies that target RNA to prevent and treat heart diseases, according to Quartz.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences